Who is sponsoring NCT05127460?

NCT05127460 is sponsored by National Defense Medical Center, Taiwan.

What drugs are being tested in NCT05127460?

Interventions in NCT05127460: AI-enabled ECG-based Screening Tool.

What condition does NCT05127460 study?

NCT05127460 studies Atrial Fibrillation New Onset.

Is NCT05127460 still recruiting?

NCT05127460 is currently completed. Last updated 28 March 2023.

Last reviewed 2023-03-28 · How we verify

NCT05127460

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

CARDIOLOGIST Trial: Artificial Intelligence Enabled Electrocardiogram for Atrial Fibrillation Detection

Completed NA Last updated 28 March 2023

What this trial tests

NA trial testing AI-enabled ECG-based Screening Tool in Atrial Fibrillation New Onset in 25,732 participants. Completed in 31 January 2023.

Timeline

1 January 2022

Primary endpoint
31 October 2022

31 January 2023

Quick facts

Lead sponsor	National Defense Medical Center, Taiwan
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	screening
Enrollment	25,732
Start date	1 January 2022
Primary completion	31 October 2022
Estimated completion	31 January 2023
Sites	1 location across Taiwan

Drugs / interventions tested

AI-enabled ECG-based Screening Tool

Conditions studied

Atrial Fibrillation New Onset — all drugs for Atrial Fibrillation New Onset →

Sponsor

National Defense Medical Center, Taiwan

Who can join

18 and older, any sex, with Atrial Fibrillation New Onset. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a randomized controlled trial (RCT) to test a novel artificial intelligence (AI)-enabled electrocardiogram (ECG)-based screening tool for improving the diagnosis and management of Atrial Fibrillation.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Artificial Intelligence-Enabled ECGs for Atrial Fibrillation Identification and Enhanced Oral Anticoagulant Adoption: A Pragmatic Randomized Clinical Trial.
Liu WT, Lin C, Lee CC, Chang CH, et al · · 2025 · cited 3× · PMID 40611485 · DOI 10.1161/jaha.125.042106

Verify or expand the search:

Other trials of AI-enabled ECG-based Screening Tool

Trials testing the same drug.

NCT05675670 — Artificial Intelligence-enable Electrocardiogram for Diagnosis and Outcome in Hyperthyroidism · NA · unknown
NCT05118009 — Artificial Intelligence Based Rapid Identification of ST-elevation Myocardial Infarction Using Electrocardiogram (ARISE) · NA · completed
NCT05118035 — Applying an Artificial Intelligence-Enabled Electrocardiographic System for Reducing Mortality · NA · completed
NCT05117970 — Artificial Intelligence-assisted Diagnosis and Prognostication in Low Ejection Fraction Using Electrocardiograms · NA · completed
NCT04000087 — ECG AI-Guided Screening for Low Ejection Fraction · NA · completed

Other recruiting trials for Atrial Fibrillation New Onset

Currently open trials in the same condition.

NCT05841056 — Short Term Anti-aRrhythmic Therapy for Post-Operative AF in Cardiac Surgery Patients Pilot Trial · Phase 3 · recruiting
NCT06275503 — STROKESTOP III - Optimized Method for Atrial Fibrillation Screening · NA · recruiting
NCT06159985 — Effect of Left Posterior Pericardiotomy for the Prevention of POAF · NA · recruiting
NCT05444335 — Screening for Atrial Fibrillation in Elderly Women Older Than 70 Years · NA · active not recruiting
NCT05229211 — Tracking Atrial Fibrillation After Intensive Care Admission · recruiting

Other National Defense Medical Center, Taiwan trials

Trials by the same sponsor.

NCT07373002 — Development and Evaluation of an Intelligent Parent-Infant Connection-Based Intervention to Strengthen Family Resilience · NA · not yet recruiting
NCT07488052 — Home-based Outpatient Multicenter Evaluation Using Electrocardiogram (HOME-ECG) · recruiting
NCT07307729 — AI-Enabled ECG Stratification and Timing of Potassium-Lowering Therapy in Patients With Hyperkalemia: A Target Trial Emu · NA · not yet recruiting
NCT07217236 — Proactive Risk Evaluation for Cardiac Implantable Electronic Device Strategy Using AI-ECG · NA · recruiting
NCT06887699 — The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value- · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05127460 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Defense Medical Center, Taiwan
Last refreshed: 28 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05127460.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing